Genmab A-S
Price & Volume
Stats
See more52W Range | $23.62-$59.97 |
Market Cap | $35.2B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $4.1B |
Revenue Growth (YoY) | 24.9% |
Gross Profit (12 Mos) | $3.8B |
Diluted EPS | $1.63 |
News
See moreYahoo Finance • 2 hours ago
Can Genmab (CPSE:GMAB) Still Be Undervalued After Its Trial Wins?
Yahoo Finance • yesterday
Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50%
Yahoo Finance • 4 days ago
Genmab shares jump 13% on colorectal cancer drug trial results
Yahoo Finance • 4 days ago
Genmab, Incyte team up to develop experimental colorectal cancer treatment
About
CEO | Dr. Jan G.J. van de Winkel Ph.D. |
CFO | Mr. Anthony Pagano CPA |
Address | Carl Jacobsens Vej 30, Copenhagen, Denmark, 2500 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 3,119 |